OtherJun 16, 2026, 05:21 PM
Hyperliquid Strategies Inc. Files S-1 Amendment for Share Resale
AI Summary
Hyperliquid Strategies Inc. (PURR) has filed an amendment to its Form S-1 registration statement, detailing the potential resale of up to 35,156,660 shares of common stock by Rorschach Advisors LLC. This includes both issued shares and shares issuable upon exercise of warrants. The filing follows a business combination with Sonnet BioTherapeutics Holdings, Inc. completed on December 2, 2025. The company's common stock is traded on the Nasdaq under the symbol 'PURR', with a closing price of $9.34 on June 15, 2026. The resale shares represent a significant portion of the company's outstanding stock.
Key Highlights
- Hyperliquid Strategies Inc. filed an amendment to its Form S-1 registration statement on June 16, 2026.
- The filing relates to the potential offer and resale of up to 35,156,660 shares of common stock by Rorschach Advisors LLC.
- These shares include 7,761,860 Advisor Issued Shares and up to 27,394,800 Advisor Warrant Shares.
- The company completed a business combination with Sonnet BioTherapeutics Holdings, Inc. on December 2, 2025.
- The common stock is listed on the Nasdaq under the symbol 'PURR'.
- As of June 15, 2026, the last sale price of the common stock was $9.34 per share.
- The Advisor Shares represent approximately 17.9% of the outstanding common stock as of June 15, 2026.
Price Impact
More from PURR